InvestorsHub Logo
Followers 10
Posts 1040
Boards Moderated 0
Alias Born 07/08/2006

Re: dr_lowenstein post# 295817

Thursday, 07/26/2018 10:48:58 PM

Thursday, July 26, 2018 10:48:58 PM

Post# of 402131
Okay. . .but my research on PD studies shows that the CCB (isradipine) seems to be the drug of choice in their efficacy trials. Previous DD posted on this board has indicated Elite and one other pharma are the only two entities in the USA who market the drug. This may bode well for Elite if the drug is deemed to be efficacious in treating of Parkinson's disease symptoms. So. . .I will wait and see how this turns out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News